Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.
Clinical Psychopharmacology Program, Addiction Research Foundation, Toronto, Ontario, Canada.
G A
GA
Higgins
P
P
Nguyen
E M
EM
Sellers
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology*; D003213:Conditioning, Psychological / Q000187:drug effects* / Q000502:physiology; D020109:Devazepide; D008297:Male; D009020:Morphine; D010671:Phenylurea Compounds; D051381:Rats; D011919:Rats, Inbred Strains; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors* / Q000145:classification / Q000502:physiology
D001570:Benzodiazepinones; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; C058121:L 365260; D009020:Morphine; D020109:Devazepide